In Re AYLOR

CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 8, 2025
Docket25-1192
StatusUnpublished

This text of In Re AYLOR (In Re AYLOR) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re AYLOR, (Fed. Cir. 2025).

Opinion

Case: 25-1192 Document: 34 Page: 1 Filed: 09/08/2025

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

IN RE: ROBERT BENSON AYLOR, I, LEIGH HEATHER MAKOVER, ROBYN AYLOR HAINES, Appellants ______________________

2025-1192 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. 15/950,246. ______________________

Decided: September 8, 2025 ______________________

ROBERT BENSON AYLOR, I, Blue Ash, OH, pro se.

LEIGH HEATHER MAKOVER, Mt. Horeb, WI, pro se.

ROBYN AYLOR HAINES, Franklin, TN, pro se.

KAKOLI CAPRIHAN, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for appellee Coke Morgan Stewart. Also represented by MICHAEL S. FORMAN, MONICA BARNES LATEEF, AMY J. NELSON. ______________________ Case: 25-1192 Document: 34 Page: 2 Filed: 09/08/2025

2 IN RE: AYLOR

Before MOORE, Chief Judge, CHEN, Circuit Judge, and ANDREWS, District Judge. 1 PER CURIAM. Appellants Robert B. Aylor, L. Heather Makover, and Robyn A. Haines appeal a decision from the Patent Trial and Appeal Board (the “Board”). We have jurisdiction pur- suant to 28 U.S.C. § 1295(a)(4)(A). BACKGROUND Appellants are the inventors of U.S. Patent Application No. 15/950,246 (the “’246 application”). The Examiner re- jected the pending claims of the ’246 application as antici- pated or obvious in light of Appellants’ prior patent applications (the “Aylor references”). Appellants argued they submitted an Application Data Sheet (“ADS”) with the ’246 application claiming priority from the Aylor refer- ences, which prevents them from being used as prior art against the ’246 application claims. The Examiner deter- mined Appellants did not properly submit or amend the ADS. The Examiner maintained the rejections. Aylor appealed to the Board. The Board affirmed the Examiner’s rejections. The Board also issued two new re- jections: an anticipation rejection for some claims and an obviousness rejection for other claims. Appellants re- quested a rehearing, which the Board denied. This appeal followed. Appellants raise four issues on appeal: (1) whether the Board properly affirmed the Examiner’s rejection over the Aylor references, (2) whether the Board properly issued new rejections, (3) whether the Board’s new rejections are supported by substantial evidence, and (4) whether

1 Honorable Richard G. Andrews, District Judge, United States District Court for the District of Delaware, sitting by designation. Case: 25-1192 Document: 34 Page: 3 Filed: 09/08/2025

IN RE: AYLOR 3

Appellants are entitled to a patent term adjustment and costs in light of a supposedly premature notice of abandon- ment. We reach only the first and fourth issues. LEGAL STANDARD We may set aside the Board’s actions if “arbitrary, ca- pricious, an abuse of discretion, or otherwise not in accord- ance with law.” 5 U.S.C. § 706(2)(A). “We review the Board’s factual findings for substantial evidence and re- view its legal conclusions de novo.” In re Cuozzo Speed Techs., LLC, 793 F.3d 1268, 1280 (Fed. Cir. 2015) (citing In re Baxter Int’l, Inc., 678 F.3d 1357, 1361 (Fed. Cir. 2012)). “Determination of a patent’s priority date is purely a question of law if the facts underlying that determination are undisputed.” Medtronic CoreValue, LLC v. Edwards Lifesciences Corp., 741 F.3d 1359, 1363 (Fed. Cir. 2014) (citing E.I. du Pont de Nemours & Co. v. MacDermid Print- ing Sols., LLC, 525 F.3d 1353, 1359 (Fed. Cir. 2008)). DISCUSSION Appellants do not challenge that the ’246 application claims are anticipated by or obvious in light of the Aylor references, if the Aylor references are prior art. Appellants argue the Aylor references are not prior art because the ’246 application claims priority from them. The underlying facts concerning priority are not in dispute, so we review the Board’s decision de novo. A U.S. patent application can claim priority from an earlier-filed U.S. patent application to gain the benefit of the earlier-filed application’s priority date. 35 U.S.C. § 120. Several requirements must be met to gain this benefit, one of which is the later-filed application must “contain a spe- cific reference to the earlier filed application.” Id. Under the regulations, a patent application must provide “the ap- plication number, the filing date, the status (including pa- tent number if available), and relationship of each application for which a benefit is claimed.” 37 C.F.R. Case: 25-1192 Document: 34 Page: 4 Filed: 09/08/2025

4 IN RE: AYLOR

§ 1.76(b)(5). This information must be submitted as part of the ADS. Id. § 1.76(a); id. § 1.78(d)(2). The claim for priority must “be submitted within the later of four months from the actual filing date of the later-filed application or six- teen months from the filing date of the prior-filed applica- tion.” Id. § 1.78(d)(3)(ii). If the deadline to file an ADS claiming priority has passed, an applicant may file a peti- tion with an ADS, certifying that “the date the benefit claim was filed was unintentional.” Id. § 1.78(e). Appellants filed the ’246 application on April 11, 2018. See SAppx. 72. 2 Appellants included an ADS with the filing and attempted to claim priority from earlier-filed applica- tions. The ADS included the earlier-filed applications’ pub- lication numbers, but it did not have their application numbers. See SAppx. 36. In a filing receipt sent on May 8, 2018, Appellants were notified that no priority was claimed and were directed to the relevant regulations. SAppx. 72. Appellants filed a replacement ADS on May 21, 2018, but it too did not include the application numbers. SAppx. 215, 221. Appellants received an updated filing receipt on May 24, 2018, again stating that no priority was claimed and directing Appellants to the relevant regulations. SAppx. 226. Appellants took no further steps to correct the ADS. 3 “Section 120 places the burden on the patent owner to provide a clear, unbroken chain of priority.” Droplets, Inc. v. E*TRADE Bank, 887 F.3d 1309, 1317 (Fed. Cir. 2018) (citing Medtronic, 741 F.3d at 1366). We have previously declined to adopt an exception to the requirements under section 120 and the regulations for a “hypertechnical viola- tion” in claiming priority. Droplets, 887 F.3d at 1316. The

2 “SAppx.” refers to the supplemental appendix filed by the government. 3 According to the Board, Appellants’ deadline to sub-

mit a proper ADS was August 13, 2018. Appellants do not dispute this. Case: 25-1192 Document: 34 Page: 5 Filed: 09/08/2025

IN RE: AYLOR 5

regulations require that Appellants provide, in the ADS for a patent application, the application numbers for all patent applications from which the pending application claims priority. 37 C.F.R. § 1.76(a); id. § 1.76(b)(5). Appellants failed to meet that requirement. Thus, the Board properly affirmed the Examiner’s use of the Aylor references as prior art.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Baxter International, Inc.
678 F.3d 1357 (Federal Circuit, 2012)
Medtronic Corevalve, LLC v. Edwards Lifesciences Corp.
741 F.3d 1359 (Federal Circuit, 2014)
In Re Cuozzo Speed Technologies, LLC
793 F.3d 1268 (Federal Circuit, 2015)
Droplets, Inc. v. Etrade Bank
887 F.3d 1309 (Federal Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
In Re AYLOR, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-aylor-cafc-2025.